- Home
- DNUT vs RCKT Comparison
DNUT vs RCKT Comparison
Compare DNUT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNUT
- RCKT
- Stock Information
- Founded
- DNUT 1937
- RCKT 1999
- Country
- DNUT United States
- RCKT United States
- Employees
- DNUT N/A
- RCKT N/A
- Industry
- DNUT Food Chains
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- DNUT Consumer Staples
- RCKT Health Care
- Exchange
- DNUT Nasdaq
- RCKT Nasdaq
- Market Cap
- DNUT 1.9B
- RCKT 1.9B
- IPO Year
- DNUT 2021
- RCKT N/A
- Fundamental
- Price
- DNUT $11.35
- RCKT $17.13
- Analyst Decision
- DNUT Buy
- RCKT Strong Buy
- Analyst Count
- DNUT 9
- RCKT 9
- Target Price
- DNUT $15.56
- RCKT $53.22
- AVG Volume (30 Days)
- DNUT 1.1M
- RCKT 731.3K
- Earning Date
- DNUT 11-07-2024
- RCKT 11-04-2024
- Dividend Yield
- DNUT 1.22%
- RCKT N/A
- EPS Growth
- DNUT N/A
- RCKT N/A
- EPS
- DNUT N/A
- RCKT N/A
- Revenue
- DNUT $1,739,779,000.00
- RCKT N/A
- Revenue This Year
- DNUT $2.13
- RCKT N/A
- Revenue Next Year
- DNUT $7.84
- RCKT $300.20
- P/E Ratio
- DNUT N/A
- RCKT N/A
- Revenue Growth
- DNUT 8.06
- RCKT N/A
- 52 Week Low
- DNUT $9.18
- RCKT $15.98
- 52 Week High
- DNUT $17.84
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- DNUT 56.23
- RCKT 46.41
- Support Level
- DNUT $11.46
- RCKT $17.05
- Resistance Level
- DNUT $11.82
- RCKT $17.75
- Average True Range (ATR)
- DNUT 0.29
- RCKT 0.72
- MACD
- DNUT 0.04
- RCKT 0.06
- Stochastic Oscillator
- DNUT 81.12
- RCKT 40.23
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S., includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line; International includes operations in the U.K., Ireland, Australia, New Zealand, and Mexico; and Market Development includes franchise operations across the globe, as well as operations in Japan. It derives maximum revenue from U.S. Segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.